Molecular mechanism of signal transduction through the Met receptor: Activation by the ligand InIB and co-receptor function of CD44v6
Molecular mechanism of signal transduction through the Met receptor: Activation by the ligand InIB and co-receptor function of CD44v6
批准号:
187647894
负责人:
Professor Dr. Mike Heilemann
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2011
资助国家:
德国
项目状态:
已结题
起止时间:
2010-12-31 至 2013-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The human receptor tyrosine kinase Met and its ligand HGF are essential during embryonic development. They also play an important role during cancer metastasis and in tissue regeneration. Moreover, several pathogens target Met during infection. The bacterium Listeria monocytogenes uses the surface protein InlB that activates Met in order to induce bacterial uptake. Studies on cells and in animals revealed that CD44v6, a splice variant of the transmembrane protein CD44, is a co-receptor essential for Met activation. While the importance of CD44v6 for Met activation by HGF and InlB is well established, the mechanism by which CD44v6 acts is still unclear. Here, we propose to study the molecular mechanism of Met activation by its ligands HGF and InlB with an emphasis on the function of the co-receptor CD44v6. We want to test whether CD44v6 directly interacts with InlB and HGF or with Met using in vitro binding experiments. The structure of binary or ternary complexes of CD44v6 with ligands and/or the receptor will be investigated by X-ray crystallography. In addition, we want to use single-molecule and super-resolution fluorescence methods to study the influence of CD44v6 on ligand-induced receptor dimerization and receptor internalization in cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Bleaching-independent, multi-color, whole-cell STED microscopy using exchangeable fluorophores
-
批准号:422735238
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Mike Heilemann
-
依托单位:
Multi-color, quantitative single-molecule localization microscopy (qSMLM) based on kinetic analysis of fluorophore blinking cycles
-
批准号:316699192
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2016
-
负责人:Professor Dr. Mike Heilemann
-
依托单位:
Mechanisms of neural Toll-like Receptor 4-signaling
-
批准号:260717323
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Professor Dr. Mike Heilemann
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
-
批准号:82371634
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵福军
-
依托单位:
生物钟核受体Rev-erbα在缺血性卒中神经元能量代谢中的改善作用及机制研究
-
批准号:82371332
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:胡琴
-
依托单位:
超声驱动压电效应激活门控离子通道促眼眶膜内成骨的作用及机制研究
-
批准号:82371103
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:阮静
-
依托单位:
骨髓ISG+NAMPT+中性粒细胞介导抗磷脂综合征B细胞异常活化的机制研究
-
批准号:82371799
-
项目类别:面上项目
-
资助金额:47.00万元
-
批准年份:2023
-
负责人:杨程德
-
依托单位:
慢性炎症诱发骨丢失的机制及外泌体靶向治疗策略研究
-
批准号:82370889
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:傅德皓
-
依托单位:
PRNP调控巨噬细胞M2极化并减弱吞噬功能促进子宫内膜异位症进展的机制研究
-
批准号:82371651
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵栋
-
依托单位:
CBP/p300-HADH轴在基础胰岛素分泌调节中的作用和机制研究
-
批准号:82370798
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:王晓
-
依托单位:
5'-tRF-GlyGCC通过SRSF1调控RNA可变剪切促三阴性乳腺癌作用机制及干预策略
-
批准号:82372743
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:陈卓佳
-
依托单位:
TIPE2调控巨噬细胞M2极化改善睑板腺功能障碍的作用机制研究
-
批准号:82371028
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:赵慧
-
依托单位: